J0205 — Injection, alglucerase, per 10 units
J0205 is a HCPCS Level II code for injection, alglucerase, per 10 units. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J0205 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0205
- Long descriptor
- Injection, alglucerase, per 10 units
- Short descriptor
- Alglucerase injection
- Added
- January 1, 1993
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0205
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0205 is not quite right, the correct code is very often within a few positions of it.
- J0178Injection, aflibercept, 1 mg
- J0179Injection, brolucizumab-dbll, 1 mg
- J0180Injection, agalsidase beta, 1 mg
- J0184Injection, amisulpride, 1 mg
- J0185Injection, aprepitant, 1 mg
- J0190Injection, biperiden lactate, per 5 mgterminated
- J0200Injection, alatrofloxacin mesylate, 100 mgterminated
- J0202Injection, alemtuzumab, 1 mg
- J0206Injection, allopurinol sodium, 1 mg
- J0207Injection, amifostine, 500 mg
- J0208Injection, sodium thiosulfate (pedmark), 100 mg
- J0209Injection, sodium thiosulfate (hope), 100 mg
- J0210Injection, methyldopate hcl, up to 250 mg
- J0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215Injection, alefacept, 0.5 mgterminated
- J0216Injection, alfentanil hydrochloride, 500 micrograms
Questions about J0205
What is HCPCS code J0205?
J0205 is a HCPCS Level II code for injection, alglucerase, per 10 units. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0205?
The CMS HCPCS file marks J0205 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0205 still valid?
No. J0205 was terminated on December 31, 2025 and should not be used on new claims.